Dr. Michael A Repka received his B.S. in Pharmacy and Ph.D. in Pharmaceutical Sciences with an emphasis in Pharmaceutics from the University of Texas at Austin. In addition, he earned his D.D.S. from the University of Texas Health Science Center at San Antonio. From a research perspective, Dr. Repka has over 30 years of experience utilizing hot-melt extrusion (HME) for pharmaceutical dosage forms and devices. Dr. Repka is a Distinguished Professor in the Department of Pharmaceutics & Drug Delivery (PDD) and Director of the Pii Center for Pharmaceutical Technology. He also served as Chair of PDD for 17 years. Dr. Repka has been awarded >$8.9 million from grants and contracts, as PI or Co-PI, from NIH, Industry, other Federal Agencies, and private support. The Department of Pharmaceutics & Drug Delivery has over 60 graduate students and thus Dr. Repka has had the opportunity to mentor, train and assist both M.S. and Ph.D. graduate students in an enriched learning environment. Dr. Repka received the Distinguished Research and Creative Achievement Award in 2020, which is the University’s highest research honor, and was named a Fellow of the American Association of Pharmaceutical Scientists in 2012. He serves as an editor for AAPS PharmSciTech and associate editor for the Journal of Drug Delivery Science and Technology, and he has served on the editorial advisory boards of nine respected pharmaceutical journals.